Completed NA INTERVENTIONAL 4-arm NCT02080845

Effects of a Cocoa Shot on the Human Brain 2

Sponsor: The Hershey Company

Conditions Caffeine

Interventions high caffeine high theobromine low theobromine no caffeine no theobromine

Updated 7 times since 2017 Last updated: Jul 16, 2018 Started: Mar 31, 2014 Primary completion: Feb 28, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Caffeine and is currently completed. The Hershey Company leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

Phase: PHASE1 → NA
Jun 2018 — Aug 2018 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Dec 2017 [monthly]

Completed PHASE1

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Hershey Company
Wake Forest University Health Sciences

Data source: Wake Forest University Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winston-Salem, United States